Search Results - "Buzón, Luis"
-
1
Weight gain in HIV-infected individuals using distinct antiretroviral drugs
Published in AIDS reviews (01-07-2020)“…Following the initiation of antiretroviral therapy, most HIV-infected individuals experience significant weight gain. It was originally thought to result from…”
Get full text
Journal Article -
2
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study
Published in Journal of antimicrobial chemotherapy (01-03-2024)“…Abstract Background Switching strategy with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) has become a gold standard for people living with HIV…”
Get full text
Journal Article -
3
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
Published in Viruses (01-04-2023)“…The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir (DTG) plus lamivudine (3TC) have led to international guidelines…”
Get full text
Journal Article -
4
Clonal spread of fluconazole‐resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID‐19 pandemic
Published in Mycoses (01-01-2024)“…Background Fluconazole‐resistant Candida parapsilosis (FRCP) is a matter of concern in Spain. Objectives We here report a FRCP spread across a 777‐bed referral…”
Get full text
Journal Article -
5
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Published in Critical care medicine (01-06-2021)“…No standard therapy, including anticoagulation regimens, is currently recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy…”
Get full text
Journal Article -
6
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic
Published in Viruses (24-01-2023)“…Dolutegravir (DTG) based dual therapies for treating PLWHIV are a standard of care nowadays. Switching to DTG and lamivudine (3TC) safety and efficacy were…”
Get full text
Journal Article -
7
Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
Published in Antibiotics (Basel) (31-05-2021)“…Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram-positive microorganisms. It also has unique…”
Get full text
Journal Article -
8
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV)
Published in Journal of clinical medicine (01-02-2023)“…Immune recovery in people living with HIV (PLWHIV) is a residual aspect of antiretroviral treatment (ART) in most patients, but in a non-negligible proportion…”
Get full text
Journal Article -
9
-
10
Why Tenofovir/Dolutegravir/Lamivudine if We Might Use Dolutegravir/Lamivudine
Published in Clinical infectious diseases (24-10-2024)Get full text
Journal Article -
11
Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
Published in Chest (01-04-2021)Get full text
Journal Article -
12
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Published in Age and ageing (01-03-2021)“…Abstract Background the coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients. Methods post hoc…”
Get full text
Journal Article -
13
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients
Published in Journal of autoimmunity (01-12-2020)“…Severely ill COVID-19 patients may end in acute respiratory distress syndrome (ARDS) and multi-organ failure. Some of them develop a systemic hyperinflammatory…”
Get full text
Journal Article -
14
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Published in Infection (01-08-2021)“…Olfactory and gustatory dysfunctions (OGD) are a frequent symptom of coronavirus disease 2019 (COVID-19). It has been proposed that the neuroinvasive potential…”
Get full text
Journal Article -
15
Rhizopus arrhizus Invasive Infection due to Self-Inflicted Scratch Injuries in a Diabetic Patient with Non-ketotic Acidosis
Published in Mycopathologia (1975) (01-10-2017)“…Mucormycosis is a rare infection caused by members included in the subphylum Mucoromycotina. Characterized by the histopathological hallmark of angioinvasion,…”
Get full text
Journal Article -
16
-
17
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart
Published in Clinical and experimental medicine (01-05-2021)“…There is limited information on the presenting characteristics, prognosis, and therapeutic approaches of young patients hospitalized for coronavirus disease…”
Get full text
Journal Article -
18
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
Published in Frontiers in endocrinology (Lausanne) (30-11-2020)“…Dysnatremia is associated with increased mortality in patients with community-acquired pneumonia. SARS-COV2 (Severe-acute-respiratory syndrome caused by…”
Get full text
Journal Article -
19
A predictive model of immune recovery for DTG + 3TC and DTG + RPV used as switching strategies in HIV+ patients
Published in Journal of antimicrobial chemotherapy (28-11-2022)Get full text
Journal Article -
20
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
Published in Clinical microbiology and infection (01-01-2023)“…To assess the effect of hydroxychloroquine (HCQ) and Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis on COVID-19 risk. EPICOS…”
Get more information
Journal Article